A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia
Clinical trial NCT03053206 · UNKNOWN
Trial details
- NCT number
- NCT03053206
- Sponsor
- All India Institute of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2019-12-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.